The TAGLN, MYL9, and TPM2 were found to be over-expressed in fibroblasts from primary tumors compared to adjacent normal tissues and were associated with a poorer prognosis in the TCGA cohort of colorectal cancer [57]. This evidence concerns the gene MYL9 and colorectal cancer.